Back to search
FDAFDA · Food and drugs·Recall number D-0750-2021

Tizanidine HCl Tablets, USP 4 mg, 150-count bottles, Rx only, Mfd By: Dr. Reddy's Laboratories limited, Srikakulam District, 532 409 INDIA, NDC 55111-180-15.

Published August 25, 2021 · Recall initiated: July 19, 2021

Summary

FDA records drug Class II recall D-0750-2021, published August 25, 2021 and initiated July 19, 2021. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 37560 bottles; Lot: Lot #: T2000471, exp date 09/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specification: Some tablets are shaved

What to do

Voluntary: Firm initiated · Letter

Get an email if TIZANIDINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TIZANIDINE
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
Nationwide within the United States
UPC
0355111180104
Lot
Lot #: T2000471, exp date 09/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tizanidine HCl Tablets, USP 4 mg, 150-count bottles, Rx only, Mfd By: Dr. Reddy's Laboratories limited, Srikakulam District, 532 409 INDIA, NDC 55111-180-15. recalled?

Yes. FDA published recall D-0750-2021 on August 25, 2021. Reported hazard: Failed Tablet/Capsule Specification: Some tablets are shaved

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TIZANIDINE. UPC: 0355111180104.